Should the 14‐day rule for embryo research become the 28‐day rule?
Abstract The “14‐day rule”—broadly construed—is used in science policy and regulation to limit research on human embryos to a maximum period of 14 days after their creation or to the equivalent stage of development that is normally attributed to a 14‐day‐old embryo (Hyun et al, 2016; Nuffield Counci...
Saved in:
| Main Authors: | John B Appleby, Annelien L Bredenoord |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2018-08-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201809437 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Literature review. Pricing rule alternatives for the European day-ahead market
by: Felix Weißensteiner
Published: (2024-04-01) -
Venetoclax schedule in AML: 7 vs 14 vs 21 vs 28 days
by: Naseema Gangat, et al.
Published: (2025-04-01) -
Showing the Many Why Philosophers Should Rule
by: Karel Thein
Published: (2024-12-01) -
Rules of Fixed Assets Accounting Should Be Changed
by: V. G. Get’man
Published: (2020-03-01) -
Attitudes of patients with IVF/ICSI toward human embryo in vitro culture beyond 14 days
by: Yukitaka Kiya, et al.
Published: (2024-06-01)